Stock info Agios Pharmaceuticals | Filter  Basic-Info

Stock: Agios Pharmaceuticals (US broad)

Last Price 29.03 Max Price 33.67
Min Price 20.39 1 Year return 3.38
Sector Health Care Subsector Biotechnology
Annual report 2017

Loading...

Contact info:Street: 38 Sidney Street,2nd FloorZip Code: MA 02139City: CambridgeCountry: USAPhone: 617-649-8600Email: info@agios.comWebsite: www.agios.comCEO: Dr. David P. Schenkein M.DCFO: Mr. Glenn Goddard(SVP Finnance)

Sector Review Agios Pharmaceuticals

Loading...
Year Turnover Total sector Market share
2019 118 141,925 0.08 %
2020 203 170,231 0.12 %
2021 0 252,886 0.00 %
2022 14 238,500 0.01 %
2023 0 0 0.00 %

Advice Agios Pharmaceuticals

No Records Found




News Agios Pharmaceuticals

No Records Found

Annual reports Agios Pharmaceuticals

2017 2018 2019 2020 2021

Profile Agios Pharmaceuticals

Agios Pharmaceuticals


Past year was a negative year for Agios Pharmaceuticals investors

The stock lost over the past 12 months at around 29 percent. Over the past 5 years Agios Pharmaceuticals' stock lost at around 0 percent in value. Agios Pharmaceuticals's revenues between 2011 and 2015 were very volatile through the time and moved between 25,11 million dollars and 59,12 million dollars. Agios Pharmaceuticals's net results between 2011 and 2015 were far from constant and moved between -23,71 million dollars and -117,73 million dollars.

Agios Pharmaceuticals's head office is based in Cambridge. Agios Pharmaceuticals mainly operates in the pharmaceutical sector. Dr. David P. Schenkein M.D is the company' CEO. Mr. Glenn Goddard(SVP Finnance) runs the company as a CFO. The period from 2006 till the end of 2016 the international sector gained around 75 percent. As from 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

Agios Pharmaceuticals didn't pay out any dividends (in the past 5 years).

Agios Pharmaceuticals's balance mostly consists of debt

As per the end of 2015 the American company's balance sheet equaled 420,07 million dollars. The total debt was around 74,95 million dollars. This is 17,84 percent of the total balance sheet. At the end of 2016 the American company was traded with a price/earnings-ratio of around -36. So investors paid -36 times the company's 2015's EPS. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a growth stock.

At the end of 2015 the pharmaceutical company's market size (her number of outstanding share times the stock price) equaled around 2,38 billion dollars. At the end of 2015 around 37,43 million stocks were listed.

All Agios Pharmaceuticals's financial reports are located here. More information about Agios Pharmaceuticals can be found it's website. .


Results Agios Pharmaceuticals

Results
2015
2016
2017
2018
2019
2020
Revenue
59
70
43
94
118
203
Costs
177
268
358
440
529
531
Profit
-118
-198
-315
-346
-411
-327
Margin of profit
-199.14
-283.97
-731.62
-366.60
-348.97
-161.11
ROI
-34.11
-55.35
-83.80
-50.33
-64.24
-81.94

Balance Agios Pharmaceuticals

Balance
2015
2016
2017
2018
2019
2020
Equity
345
359
376
688
641
400
Debt
75
261
239
171
250
453
Total assets
420
619
614
858
891
853
Solvency
82.16
57.92
61.12
80.09
71.91
46.84
Cash
317
541
424
585
565
573
Cashflow
-77
39
-285
-304
-371
-291
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
-1.03
0.15
-1.19
-1.78
-1.48
-0.64

Details Agios Pharmaceuticals

Details
2016
2017
2018
2019
2020
Price
64.92
41.73
57.17
46.11
47.75
Eps
-5.07
-6.75
-6.03
-6.86
-4.74
Price/earnings-ratio
-12.80
-6.18
-9.48
-6.72
-6.12
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
8.49
7.69
11.81
9.36
5.77
Market to book
0.13
0.18
0.21
0.20
0.20
Cashflow per stock
0.91
-5.84
-5.23
-5.42
-4.20
Stocks
42
49
58
68
69
Market Cap
2.740.95
2.037.52
3.328.36
3.153.97
2.011.60

Dividend Agios Pharmaceuticals


Price info Agios Pharmaceuticals

Date
Price
22 Apr 2024
29.03
18 Apr 2024
29.03
17 Apr 2024
28.80
09 Apr 2024
27.70
05 Apr 2024
27.92
03 Apr 2024
28.67
30 Mar 2024
29.24
22 Mar 2024
30.24
18 Mar 2024
29.94
15 Mar 2024
29.46
12 Mar 2024
30.80
11 Mar 2024
31.29
09 Mar 2024
31.29
07 Mar 2024
31.79
01 Mar 2024
32.32
29 Feb 2024
33.67
27 Feb 2024
32.87
22 Feb 2024
26.80
21 Feb 2024
27.10
20 Feb 2024
26.51
15 Feb 2024
25.90
14 Feb 2024
25.15
13 Feb 2024
25.88
09 Feb 2024
24.18
08 Feb 2024
23.69
07 Feb 2024
24.15
06 Feb 2024
23.73
05 Feb 2024
23.09
01 Feb 2024
22.62
31 Jan 2024
22.86